Clinical Trial Update: DevRobust Treatment for Mal de Débarquement Syndrome [NA]

View source ↗

Summary

Clinical trial update indicating a DevRobust treatment is being studied for Mal de Débarquement Syndrome and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mal De Débarquement Syndrome

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Mal de Débarquement Syndrome | NA | Status: RECRUITING